dihexa retracted paper controversy One in six of the papers you cite in a review has been retracted. What do you do? – Retraction Watch The Peer‑Review Problem and the

What follows reflects protocols documented in research literature and clinical practice settings

This information does not claim that BPC-157 or TB-500 treats, cures, or prevents any disease or injury

Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis

If the solution was initially clear and becomes cloudy after storage, the peptide may be aggregating or precipitating

Full hyperlink: North Tees and Hartlepool NHS Foundation Trust

In each case, the experts agreed with the FDA, voting that the substances were too risky to be compounded